Answers are grounded in this paper and cite their sources.
Cross-sectional survey identifies risk factors for emotional suppression in MRD-positive leukemia patients, suggesting needed psychosocial interventions.
The presence of minimal residual disease (MRD) in acute leukemia patients post-chemotherapy is a crucial prognostic factor. This study aims to investigate the prevalence and determinants of emotional suppression in MRD-positive acute leukemia patients to inform targeted interventions. We conducted a cross-sectional survey of 139 MRD-positive acute leukemia patients undergoing chemotherapy at a tertiary hospital in Handan, Hebei province (January 2023–December 2024). Patients completed validated measures assessing emotional suppression, social constraints, and alexithymia (Toronto Alexithymia Scale-20). Multivariate regression analysis identified Age, disease stage, relapse status, insurance type (out-of-pocket vs. insured), social constraints, and alexithymia as significant predictors of emotional suppression (all P<0.001), accounting for 68.6% of the variance in emotional suppression scores.. Notably, the mean emotional suppression score was 31.07±4.85. Significant positive correlations were observed between emotional suppression and social constraints (r=0.609, P<0.01) as well as between emotional suppression and alexithymia (r=0.232, P<0.01). These findings underscore the elevated emotional suppression experienced by MRD-positive acute leukemia patients. Patients with advanced Age, high-risk disease, relapse, out-of-pocket expenses, high social constraints, and alexithymia are particularly vulnerable. Targeted psychological interventions are warranted to reduce emotional suppression, thereby improving psychological well-being and quality of life in this patient population.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: